Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
Document Type
Journal Article
Publication Date
4-1-2017
Journal
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter
Volume
65
Issue
4
DOI
10.1016/j.jvs.2016.03.407
Keywords
AC133 Antigen; Angiogenesis Inducing Agents; Animals; Antigens, CD34; Cell Hypoxia; Cell Movement; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Progenitor Cells; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Male; Mice, Knockout; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Skin Ulcer; Time Factors; Vascular Endothelial Growth Factor Receptor-2; Wound Healing
APA Citation
Zhou, X., Patel, D., Sen, S., Shanmugam, V., Sidawy, A., Mishra, L., & Nguyen, B. (2017). Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter, 65 (4). http://dx.doi.org/10.1016/j.jvs.2016.03.407
Peer Reviewed
1
